Analyst Ranking
Bottom 2%
#5407 out of 5504 analysts
Average Return
-4.52%
Win Rate
35%83 out of 236
Risk vs Reward
Poor
Good

Michael Petusky's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Haemonetics CorpHAE
+137.12%$42.92$101.77
2017-08-08 -
2018-08-08
Buy
Lifecore Biomedical IncLFCR
+131.94%$3.10$7.19
2023-03-20 -
2024-03-19
Buy
Anika Therapeutics IncANIK
+128.18%$9.12$20.81
2025-09-23 -
2026-09-04
Buy
Anika Therapeutics IncANIK
+118.90%$8.26$18.07
2025-07-31 -
2026-07-30
Buy
Anika Therapeutics IncANIK
+118.59%$9.52$20.81
2026-01-09 -
2026-09-04
Buy

Michael Petusky Analyst Color

Get additional color on Michael Petusky's coverage of popular stocks

Michael Petusky's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Haemonetics CorpHAE
30Buy$118.00+14.65%Maintains
17 days ago
U S Physical Therapy IncUSPH
24Buy$98.00+23.50%Maintains
a month ago
Orthofix Medical IncOFIX
9Buy$17.00+82.99%Maintains
2 months ago
Bioventus IncBVS
4Buy$14.00-0.50%Maintains
2 months ago
Lifecore Biomedical IncLFCR
15Buy$6.50+47.73%Maintains
3 months ago
Lemaitre Vascular IncLMAT
17Buy$120.00+48.75%Maintains
3 months ago
Option Care Health IncOPCH
20Buy$32.00+32.18%Maintains
4 months ago
Opko Health IncOPK
13HoldN/AN/ADowngrades
4 months ago
Merit Medical Systems IncMMSI
27Buy$107.00+19.42%Maintains
5 months ago
Dentsply Sirona IncXRAY
23Buy$17.00+49.38%Maintains
6 months ago
Anika Therapeutics IncANIK
18Buy$17.00-18.31%Maintains
6 months ago
Henry Schein IncHSIC
19Buy$97.00+8.01%Maintains
6 months ago
Verifyme IncVRME
11Buy$1.50+148.34%Maintains
8 months ago
Surmodics IncSRDX
8SellN/AN/ADowngrades
10 months ago
Modivcare IncMODVQ
13Buy$6.00N/AMaintains
a year ago
Ati Physical Therapy IncATIP
2HoldN/AN/ADowngrades
5 years ago
Pharmerica CorpPMC
1SellN/AN/ADowngrades
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.